Related Experiment Video
Updated: Dec 20, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
Ilir Maraj1, Mario D Gonzalez1, Gerald V Naccarelli1
1Cardiology Division/EP Section, Department of Medicine, Heart and Vascular Institute, Penn State Health Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA.
Insights
Atrial fibrillation (AF) increases stroke risk fivefold. This review covers anticoagulant drugs for stroke prevention before, during, and after catheter ablation in AF patients.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia with a significant risk of stroke and thromboembolism.
- Oral anticoagulation is standard for stroke prevention in AF patients.
- Alternative stroke prevention methods like left atrial appendage occlusion are used for high-bleeding-risk patients.
Purpose of the Study:
- To review anticoagulant drug options for patients undergoing catheter ablation for AF.
- To discuss the peri-procedural use of anticoagulants in AF catheter ablation.
Main Methods:
- Literature review of anticoagulant therapies.
- Analysis of current guidelines and clinical practices.
Main Results:
- Anticoagulant management is crucial for stroke prevention in AF patients undergoing ablation.
- Specific anticoagulant strategies are employed before, during, and after catheter ablation procedures.
Conclusions:
- Optimizing anticoagulant therapy is essential for improving outcomes in AF patients undergoing catheter ablation.
- A comprehensive understanding of anticoagulant options supports effective stroke risk management in this population.
Abstract:
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice today. For those who present with it, one of the most major risks associated with the condition is stroke. AF is associated with a fivefold increased risk of stroke and thromboembolism. Oral anticoagulation has been the cornerstone of stroke prevention in patients with AF. In some individuals who exhibit a higher risk of bleeding, other alternatives for stroke prevention have been sought, including the use of left atrial appendage occlusion devices and surgical exclusion of the left atrial appendage. Catheter ablation is an important treatment strategy in those patients for whom a rhythm control strategy has been selected. This article reviews some of the available anticoagulant drug options and their use prior to, during, and after catheter ablation.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization I: Pre-Procedure Overview
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

